Berlin - Delayed Quote • EUR
G1 Therapeutics Inc (G1H.BE)
As of 11:58 AM GMT+2. Market Open.
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
121,540.0000
187,965.0000
254,094.0000
228,552.0000
Total Liabilities Net Minority Interest
86,154.0000
119,218.0000
110,553.0000
51,201.0000
Total Equity Gross Minority Interest
35,386.0000
68,747.0000
143,541.0000
177,351.0000
Total Capitalization
86,943.0000
145,762.0000
218,731.0000
197,244.0000
Common Stock Equity
35,386.0000
68,747.0000
143,541.0000
177,351.0000
Capital Lease Obligations
4,340.0000
5,615.0000
6,750.0000
7,865.0000
Net Tangible Assets
35,386.0000
68,747.0000
143,541.0000
177,351.0000
Working Capital
85,232.0000
143,912.0000
215,952.0000
192,949.0000
Invested Capital
86,943.0000
145,762.0000
218,731.0000
197,244.0000
Tangible Book Value
35,386.0000
68,747.0000
143,541.0000
177,351.0000
Total Debt
55,897.0000
82,630.0000
81,940.0000
27,758.0000
Net Debt
19,339.0000
--
--
--
Share Issued
51,952.7410
51,526.1000
42,588.8140
38,140.7560
Ordinary Shares Number
51,926.0750
51,499.4340
42,562.1480
38,114.0900
Treasury Shares Number
26.6660
26.6660
26.6660
26.6660
12/31/2020 - 5/8/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade